CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-03 | Baroldi Joseph EVP, Chief Business Officer | Option exercise 10b5-1 | +2,800 | $31.80 | $89K | 34,726 |
| 2025-09-03 | Baroldi Joseph EVP, Chief Business Officer | Sale 10b5-1 | −2,800 | $62.01 | $174K | 31,926 |
| 2025-09-03 | Baroldi Joseph EVP, Chief Business Officer | Option exercise 10b5-1 | +15,000 | $31.80 | $477K | 46,926 |
| 2025-09-03 | Baroldi Joseph EVP, Chief Business Officer | Sale 10b5-1 | −30,000 | $59.09 | $1.8M | 16,926 |
| 2025-09-03 | Baroldi Joseph EVP, Chief Business Officer | Option exercise 10b5-1 | +15,000 | $31.80 | $477K | 31,926 |
| 2025-09-03 | Baroldi Joseph EVP, Chief Business Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −2,800 | 83,900 | ||
| 2025-09-03 | Baroldi Joseph EVP, Chief Business Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −15,000 | 68,900 | ||
| 2025-09-03 | Baroldi Joseph EVP, Chief Business Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −15,000 | 53,900 | ||
| 2025-09-03 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise 10b5-1 | +14,000 | $37.58 | $526K | 71,130 |
| 2025-09-03 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −65,475 | $60.89 | $4.0M | 5,655 |
| 2025-09-03 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise 10b5-1 | +13,050 | $32.60 | $425K | 18,705 |
| 2025-09-03 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −11,375 | $61.42 | $699K | 7,330 |
| 2025-09-03 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise 10b5-1 | +49,800 | $53.77 | $2.7M | 57,130 |
| 2025-09-03 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −13,050 | 4,467 | ||
| 2025-09-03 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −14,000 | 8,942 | ||
| 2025-09-03 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −49,800 | 0 | ||
| 2025-09-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise 10b5-1 | +46,800 | $53.77 | $2.5M | 135,479 |
| 2025-09-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −33,909 | $60.62 | $2.1M | 101,570 |
| 2025-09-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise 10b5-1 | −12,891 | $61.50 | $793K | 88,679 |
| 2025-09-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −46,800 | 0 |
Page 26 of 34 · 668 trades